PMID- 36387364 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20221118 IS - 1741-427X (Print) IS - 1741-4288 (Electronic) IS - 1741-427X (Linking) VI - 2022 DP - 2022 TI - Tetramethylpyrazine and Paeoniflorin Synergistically Attenuate Cholesterol Efflux in Macrophage Cells via Enhancing ABCA1 and ABCG1 Expression. PG - 4304790 LID - 10.1155/2022/4304790 [doi] LID - 4304790 AB - The formation of foam cells is a characteristic of the occurrence and development of atherosclerosis. ATP-binding cassette subfamily A1 and G1 (ABCA1 and ABCG1) and scavenger receptor B1 (SR-B1) play critical roles in promoting intracellular cholesterol efflux to high-density lipoprotein (HDL) or apolipoprotein A1 (apoA1). We attempted to test the effect of the tetramethylpyrazine-paeoniflorin pair (TP) on cholesterol outflow in foam cells derived from macrophages. In this study, RAW264.7 macrophages were treated with 80 mg/L oxidized low-density lipoprotein (ox-LDL) for 24 h to obtain foam cells. Then they were intervened with TP (tetramethylpyrazine 40 ug/ml plus paeoniflorin 80 ug/ml) for additional 24 h. The distribution of cholesterol in foam cells was evaluated by oil red O staining. The contents of total cholesterol (TC) and free cholesterol (FC) were assessed with commercial kits. Fluorescent imaging was observed with a fluorescent inverted microscope. The capacity of cholesterol efflux was measured with a fluorescent plate reader, and the transcript and protein levels of ABCA1, ABCG1, and SR-B1 were detected by Western blot and quantitative polymerase chain reactions (Q-PCRs). Cytokines in the medium were detected by ELISA and adjusted by total cellular proteins. The results showed that TP decreased ox-LDL-induced cholesterol deposition and foam cell formation by promoting cholesterol efflux to apoA1, which was related to the upregulation of ABCA1 and ABCG1. Moreover, TP decreased the secretion of ox-LDL-induced tumor necrosis factor alpha (TNF-alpha), interleukin 1 beta (IL-1beta), and monocyte chemotactic protein-1 (MCP-1), an important profoam cell cytokine in atherosclerosis. CI - Copyright (c) 2022 Jun Mei et al. FAU - Mei, Jun AU - Mei J AUID- ORCID: 0000-0003-2431-1113 AD - Graduate School,, Beijing University of Chinese Medicine, Beijing, China. AD - Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. FAU - Xu, Fengqin AU - Xu F AUID- ORCID: 0000-0002-1068-1087 AD - Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. FAU - Zhou, Qingbing AU - Zhou Q AD - Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. FAU - Zhang, Ying AU - Zhang Y AD - Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. FAU - Ji, Jie AU - Ji J AD - Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. FAU - Li, Meng AU - Li M AD - Graduate School,, Beijing University of Chinese Medicine, Beijing, China. LA - eng PT - Journal Article DEP - 20221105 PL - United States TA - Evid Based Complement Alternat Med JT - Evidence-based complementary and alternative medicine : eCAM JID - 101215021 PMC - PMC9653297 COIS- The authors have declared no conflicts of interest. EDAT- 2022/11/18 06:00 MHDA- 2022/11/18 06:01 PMCR- 2022/11/05 CRDT- 2022/11/17 11:58 PHST- 2022/03/23 00:00 [received] PHST- 2022/09/28 00:00 [revised] PHST- 2022/10/29 00:00 [accepted] PHST- 2022/11/17 11:58 [entrez] PHST- 2022/11/18 06:00 [pubmed] PHST- 2022/11/18 06:01 [medline] PHST- 2022/11/05 00:00 [pmc-release] AID - 10.1155/2022/4304790 [doi] PST - epublish SO - Evid Based Complement Alternat Med. 2022 Nov 5;2022:4304790. doi: 10.1155/2022/4304790. eCollection 2022.